Condition
Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trials that are recruiting, at sites in 13 countries (most in Germany (2), Argentina (1), Australia (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 13Countries
Newest Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Imzokitug with Pumitamig and PDCT as first-line treatment for locally advanced or metastatic NSCLC | Phase 2 | Washington D.C., District of Columbia and 73 other locations | Recruiting | Jul 2, 2026 |
| Anti-PD-1/PD-L1 with bevacizumab and low-dose cyclophosphamide for metastatic NSCLC and cutaneous melanoma after prior checkpoint therapy | Phase 2 | Saint Petersburg, Sankt-Peterburg | Recruiting | Aug 19, 2025 |
| Platform for assessing molecular testing and treatment outcomes in lung cancer patients | — | Oldenburg | Recruiting | Dec 4, 2015 |
All recruiting trials (3)
-
Imzokitug with Pumitamig and PDCT as first-line treatment for locally advanced or metastatic NSCLC
This trial tests whether adding Imzokitug to Pumitamig plus platinum-doublet chemotherapy helps people with newly diagnosed locally advanced or metastatic NSCLC.
-
Anti-PD-1/PD-L1 with bevacizumab and low-dose cyclophosphamide for metastatic NSCLC and cutaneous melanoma after prior checkpoint therapy
We will try giving anti-PD-1/PD-L1 drugs together with bevacizumab and continuous low-dose cyclophosphamide to people with metastatic NSCLC or cutaneous melanoma whose cancer progressed after prior immune checkpoint treatment.
-
Platform for assessing molecular testing and treatment outcomes in lung cancer patients
This study is trying to gather and analyze information about treatments and outcomes for people with lung cancer to improve care and understand their quality of life better.
Related topics
Quick answers
How many Metastatic Non-small Cell Lung Cancer (NSCLC) clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in Germany (2 trials), Argentina (1 trial), Australia (1 trial), Brazil (1 trial), Chile (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.